Humacyte, Inc. - Common Stock (NQ:HUMA)

0.4450 -0.0273 (-5.78%)

Delayed Quote Updated: 12:30 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Humacyte, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA

September 04, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA

August 10, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now

June 30, 2026

Via AB Newswire

Topics Artificial Intelligence

MissionIRNewsBreaks – Humacyte Inc. (NASDAQ: HUMA) Prices $50 Million Public Offering

June 16, 2026

Via Investor Brand Network

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

May 08, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

April 13, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

BioMedNewsBreaks — Humacyte, Inc. (NASDAQ: HUMA) Announces $60 Million Registered Direct Offering of Common Stock and Warrants

October 15, 2025

Via Investor Brand Network

D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering

October 14, 2025

Via ACCESS Newswire

Trestle Bio Announces Research Collaboration with Humacyte

March 06, 2025

From Trestle Biotherapeutics, Inc.

Via Business Wire

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

January 23, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

January 17, 2025

From The Schall Law Firm

Via Business Wire

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

January 17, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Faruqi & Faruqi Reminds Humacyte Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA

January 17, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

January 16, 2025

From Schall Law

Via GlobeNewswire

Deadline Soon: Humacyte, Inc. (HUMA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

January 15, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

HUMA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

January 14, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wolfspeed, Xerox, Visa, and Humacyte and Encourages Investors to Contact the Firm

January 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

January 13, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

January 10, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

January 07, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PACS Group, Chipotle, Hasbro, and Humacyte and Encourages Investors to Contact the Firm

January 06, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Kirby McInerney LLP Urges Investors in Humacyte, Inc. to Inquire About Their Rights in Class Action Lawsuit

December 31, 2024

From Kirby McInerney LLP

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Humacyte to Contact Us to Have Their Losses Evaluated Today

December 31, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

December 30, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

December 30, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm

December 26, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

HUMA Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About the Class Action Against Humacyte, Inc.

December 24, 2024

From Robbins LLP

Via GlobeNewswire

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm

December 23, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

December 23, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

December 20, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.